{"prompt": "['Protocol RS-001', 'Confidential', 'LIST OF ABBREVIATIONS AND ACRONYMS', 'AED', 'anti-epileptic drug', 'ALP', 'alkaline phosphatase', 'ALT', 'alanine aminotransferase', 'ANC', 'absolute neutrophil count', 'AST', 'aspartate aminotransferase', 'ATC', 'Anatomical Therapeutic Chemical (Classification System)', 'AUC', 'area under the curve', 'BUN', 'blood urea nitrogen', 'CBC', 'complete blood cell (count)', 'CR', 'complete response', 'CRA', 'Clinical Research Associate', 'CRF', 'case report form', 'CSF', 'cerebral spinal fluid', 'CTCEA', 'Common Terminology Criteria for Adverse Events', 'CTMS', 'Clinical Trial Management System', 'DLT', 'dose limiting toxicity', 'DSMC', 'Data and Safety Monitoring Committee', 'DSMP', 'Data and Safety Monitoring Plan', 'FCBP', 'female of childbearing potential', 'FDA', 'Food and Drug Administration', 'GCP', 'Good Clinical Practice', 'HBeAg', 'Hepatitis B \"e\" antigen', 'HBV', 'hepatitis B virus', 'HCV', 'hepatitis C virus', 'HGB', 'hemoglobin', 'HIV', 'human immunodeficiency virus', 'ICH', 'International Conference on Harmonization', 'IND', 'investigational new drug application', 'IRB', 'Institutional Review Board', 'IV', 'intravenous', 'LDH', 'lactate dehydrogenase', 'LFT', 'liver function test', 'MedDRA', 'Medical Dictionary for Regulatory Activities', 'MRI', 'magnetic resonance imaging', 'MTD', 'maximum tolerated dose', 'NCI', 'National Cancer Institute', 'ORR', 'overall response rate', 'PEComa', 'perivascular epithelioid tumor', 'PO', 'Per os (by mouth, orally)', 'RBC', 'red blood cell (count)', 'SD', 'standard deviation', 'SGA', 'subependymal giant cell astrocytoma', 'SGOT', 'serum glutamic oxaloacetic transaminase', 'SGPT', 'serum glutamic pyruvic transaminase', 'TSC', 'Tuberous Sclerosis Complex', 'Version 2', 'Version Date: October 31, 2018', 'Page 6 of 72']['Protocol RS-001', 'Confidential', 'ULN', 'upper limit of normal', 'WBC', 'white blood cell (count)', 'Version 2', 'Version Date: October 31, 2018', 'Page 7 of 72']['Protocol RS-001', 'Confidential', 'STUDY COMMITTEE', 'Principle Investigator/Study Chair', 'Jason Hauptman, MD, PhD', 'Neurosurgery', \"Seattle Children's Hospital\", '4800 Sand Point Way NE', 'Seattle, WA 98105', '206.987.2544', 'Jason.hauptman@seattlechildrens.org', 'Study Co-Chair', 'Sarah Leary, MD', 'Hematology/Oncology', \"Seattle Children's Hospital\", '4800 Sand Point Way NE', 'Seattle, WA 98105', '206.987.2106', 'Sarah.leary@seattlechildrens.org', 'Study Co-Chair', 'Russell Saneto, DO, PhD', 'Neurology', \"Seattle Children's Hospital\", '4800 Sand Point Way NE', 'Seattle, WA 98105', '206.987.2078', 'Russ.saneto@seattlechildrens.org', 'Study Statistician', 'Frankline Onchiri, PhD', \"Seattle Children's Research Institute\", '1900 9th Ave.', 'Seattle, WA 98101', '206.884.1593', 'Frankline.onchiri@seattlechildrens.org', 'Version 2', 'Version Date: October 31, 2018', 'Page 8 of 72']\n\n###\n\n", "completion": "END"}